A61P 5/44
Glucocorticosteroids
Official title: Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
A61P5/44 (Glucocorticosteroids) appears on 264 US grants and 433 published applications in this corpus.
Search patents in A61P- Granted patents
- 264
- Published applications
- 433
- Assignees
- 217
- Inventors
- 850
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 1 |
| 2002 | 4 | 14 |
| 2003 | 6 | 19 |
| 2004 | 5 | 29 |
| 2005 | 8 | 20 |
| 2006 | 11 | 20 |
| 2007 | 12 | 17 |
| 2008 | 4 | 21 |
| 2009 | 14 | 32 |
| 2010 | 12 | 30 |
| 2011 | 20 | 27 |
| 2012 | 18 | 26 |
| 2013 | 25 | 20 |
| 2014 | 15 | 15 |
| 2015 | 13 | 15 |
| 2016 | 9 | 20 |
| 2017 | 18 | 18 |
| 2018 | 10 | 10 |
| 2019 | 10 | 18 |
| 2020 | 8 | 7 |
| 2021 | 8 | 11 |
| 2022 | 4 | 5 |
| 2023 | 6 | 12 |
| 2024 | 4 | 9 |
| 2025 | 3 | 8 |
| 2026 | 2 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating glucocorticoid excess15 Sep 2026US 12,734,155 B2Sparrow Pharmaceuticals, Inc.
- Methods and compositions for treating glucocorticoid excess15 Sep 2026US 12,734,156 B2Sparrow Pharmaceuticals, Inc.
- Budesonide 21-phosphate salts and pharmaceutical compositions containing the same11 Nov 2025US 12,465,614 B2Genetic S.P.A.
- Microbial compositions to increase the production of PCA from polyphenols22 Jul 2025US 12,364,718 B2Church & Dwight Co., Inc.
- Methods and compositions for treating glucocorticoid excess17 Jun 2025US 12,329,745 B2Sparrow Pharmaceuticals, Inc.
- Glucocorticoid receptor agonist and conjugate thereof16 Jul 2026US 2026/0199497 A1Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Thixotropic delivery systems25 Jun 2026US 2026/0174871 A1The University of Montana
- Methods and compositions for treating glucocorticoid excess21 May 2026US 2026/0137656 A1Sparrow Pharmaceuticals, Inc.
- Methods and compositions for treating glucocorticoid excess21 May 2026US 2026/0137657 A1Sparrow Pharmaceuticals, Inc.
- Methods and compositions for treating glucocorticoid excess21 May 2026US 2026/0137658 A1Sparrow Pharmaceuticals, Inc.
Most cited
By later US patents
- ActRII receptor polypeptides, methods and compositions121US 7,709,605 B2Acceleron Pharma Inc. · 2010
- Anti-integrin antibodies, compositions, methods and uses101US 7,163,681 B2Centocor, Inc. · 2007
- Actriib-Fc polynucleotides, polypeptides, and compositions83US 8,252,900 B2Acceleron Pharma Inc. · 2012
- Anti-inflammatory androstane derivative75US 7,101,866 B2Glaxo Group Limited · 2006
- Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions72US 5,482,934 AEspecialidades Latinas Medicamentos Universales, S.A. (Elmu, S.A.) · 1996